BioSniper
ZH
Toggle language
Open menu
Earnings Report
positive
Earnings Report
April 8, 2026
Company
Nurix Therapeutics, Inc. (NRIX)
Other upcoming events for NRIX
Phase 3 Readout
Phase 3 Topline: A Phase 3, Randomized, Open-label, Multicenter Study of NX-5948 Versus Pirtobrutinib in Relapsed/Ref
Jun 1, 2032
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
NRIX Overview
PDUFA Dates
Phase 3 Readouts
Earnings Report — NRIX Earnings Report | BioSniper